FdaApplication

NDA 212489

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAMNEAL PHARMACEUTICALS LLC
application_typeNDA
approval_date2020-04-24

Products (2)

ProductActive ingredientStrengthDosage form
ONGENTYSOPICAPONE50MGCAPSULE;ORAL
ONGENTYSOPICAPONE25MGCAPSULE;ORAL

2 products